Contact Information for Tamoxifen Delivered Through the Breast Skin to Control ER+ DCIS Before Surgery
The sites for this trial are listed below.
If you speak with a site, please mention that you were referred by BreastCancerTrials.org
Northwestern University,
Chicago,
IL,
60611
| Contact person: |
Seema A. Khan, MD |
| Phone: | 312-503-4236 |
| Email: |
skhan@nm.org |
Saint Elizabeth Medical Center South,
Edgewood,
KY,
41017
| Contact person: |
Joseph M. Guenther, MD |
| Phone: | 859-344-1600 |
| Email: |
Joseph.Guenther@stelizabeth.com |
Mayo Clinic,
Rochester,
MN,
55905
| Contact person: |
Amy C. Degnim, MD |
| Phone: | 507-284-4499 |
| Email: |
degnim.amy@mayo.edu |
Memorial Sloan-Kettering Cancer Center,
New York,
NY,
10065
| Contact person: |
Melissa L. Pilewskie, MD |
| Phone: | 646-888-4590 |
| Email: |
pilewskm@mskcc.org |
Duke University Medical Center,
Durham,
NC,
27710
| Contact person: |
Eun-Sil (Shelley) Hwang, MD |
| Phone: | 919-684-6849 |
| Email: |
shelly.hwang@duke.edu |
Cleveland Clinic,
Cleveland,
OH,
44106
| Contact person: |
Stephen R. Grobmyer, MD |
| Phone: | 216-636-2843 |
| Email: |
TaussigResearch@ccf.org |
